HOXA13 Gene Hand-foot-uterus syndrome Genetic Test
At DNA Labs UAE, we offer the HOXA13 Gene Hand-foot-uterus syndrome Genetic Test at a cost of 4400.0 AED.
Test Details
The HOXA13 gene is responsible for providing instructions to make a protein called homeobox A13, which plays a crucial role in the development of limbs, genitals, and other related structures in the body. Mutations in the HOXA13 gene can lead to a condition called Hand-foot-uterus syndrome (HFUS), also known as Hand-foot-genital syndrome.
HFUS is a rare genetic disorder characterized by limb abnormalities, such as missing or underdeveloped fingers or toes, and malformation of the uterus in females. Other features may include abnormalities of the feet, such as fusion of the bones or missing toes, as well as genital abnormalities in both males and females.
Next-generation sequencing (NGS) genetic testing is a method used to analyze the DNA sequence of genes, including the HOXA13 gene. This test can detect mutations or changes in the gene that may be responsible for causing HFUS. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive genetic analysis.
By performing an NGS genetic test for the HOXA13 gene, doctors can confirm the diagnosis of HFUS and provide appropriate genetic counseling and management for affected individuals and their families. This information can also be used to understand the inheritance pattern of the condition and assess the risk of recurrence in future pregnancies.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Dysmorphology
- Doctor: Pediatrics
- Test Department: Genetics
Pre Test Information
Before undergoing the HOXA13 Gene Hand-foot-uterus syndrome Genetic Test, it is important to provide the clinical history of the patient who is going for the test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with HOXA13 Gene Hand-foot-uterus syndrome NGS Genetic DNA Test gene HOXA13.
Test Name | HOXA13 Gene Hand-foot-uterus syndrome Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for HOXA13 Gene Hand-foot-uterus syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with HOXA13 Gene Hand-foot-uterus syndrome NGS Genetic DNA Test gene HOXA13 |
Test Details |
The HOXA13 gene is responsible for providing instructions to make a protein called homeobox A13, which plays a crucial role in the development of limbs, genitals, and other related structures in the body. Mutations in the HOXA13 gene can lead to a condition called Hand-foot-uterus syndrome (HFUS), also known as Hand-foot-genital syndrome. HFUS is a rare genetic disorder characterized by limb abnormalities, such as missing or underdeveloped fingers or toes, and malformation of the uterus in females. Other features may include abnormalities of the feet, such as fusion of the bones or missing toes, as well as genital abnormalities in both males and females. Next-generation sequencing (NGS) genetic testing is a method used to analyze the DNA sequence of genes, including the HOXA13 gene. This test can detect mutations or changes in the gene that may be responsible for causing HFUS. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive genetic analysis. By performing an NGS genetic test for the HOXA13 gene, doctors can confirm the diagnosis of HFUS and provide appropriate genetic counseling and management for affected individuals and their families. This information can also be used to understand the inheritance pattern of the condition and assess the risk of recurrence in future pregnancies. |